Carnegie acted as lead manager in the secondary placing of 3 million shares at a price of SEK 240 per share. Meda is one of Europe’s leading specialty pharma companies. February, 2007.
Healthcare
Secondary placing of 3 million shares in Meda (SE) — SEK 720 million
February 2007